Liver	B:C0019158
Inflammation	I:C0019158
Relates	O
to	O
Decreased	O
Canalicular	O
Bile	O
Transporter	I:C0618375
Expression	O
in	O
Pediatric	O
Onset	O
Intestinal	O
Failure	I:C0012634
.	O

Liver	O
Inflammation	I:C0019158
Relates	O
to	O
Decreased	O
Canalicular	B:C0005393
Bile	O
Transporter	I:C0618375
Expression	O
in	O
Pediatric	O
Onset	O
Intestinal	O
Failure	I:C0012634
.	O

Liver	O
Inflammation	I:C0019158
Relates	O
to	O
Decreased	O
Canalicular	O
Bile	B:C0618375
Transporter	I:C0618375
Expression	O
in	O
Pediatric	O
Onset	O
Intestinal	O
Failure	I:C0012634
.	O

Liver	O
Inflammation	I:C0019158
Relates	O
to	O
Decreased	O
Canalicular	O
Bile	O
Transporter	I:C0618375
Expression	B:C1171362
in	O
Pediatric	O
Onset	O
Intestinal	O
Failure	I:C0012634
.	O

Liver	O
Inflammation	I:C0019158
Relates	O
to	O
Decreased	O
Canalicular	O
Bile	O
Transporter	I:C0618375
Expression	O
in	O
Pediatric	O
Onset	O
Intestinal	B:C0012634
Failure	I:C0012634
.	O

Although	O
liver	B:C0023895
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	B:C0009566
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	B:C0030547
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	B:C0030547
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	B:C0012634
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	B:C0012634
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	O
remains	O
unclear	O
.	O

Although	O
liver	O
disease	I:C0023895
is	O
a	O
major	O
complication	O
of	O
parenteral	O
nutrition	I:C0030547
(	O
parenteral	O
nutrition	I:C0030547
)	O
for	O
intestinal	O
failure	I:C0012634
(	O
intestinal	O
failure	I:C0012634
)	O
,	O
its	O
pathogenesis	B:C0699748
remains	O
unclear	O
.	O

We	O
investigated	O
potential	O
molecular	O
mechanisms	O
of	O
liver	B:C0160390
injury	I:C0160390
in	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
.	O

We	O
investigated	O
potential	O
molecular	O
mechanisms	O
of	O
liver	O
injury	I:C0160390
in	O
pediatric	O
onset	O
intestinal	B:C0012634
failure	I:C0012634
.	O

Liver	B:C0023884
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	B:C1171362
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	B:C0005393
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	B:C0031676
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	B:C1260069
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	B:C0005390
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	B:C1313221
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	B:C0038323
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	B:C0971221
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	B:C0007292
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	B:C0033684
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	B:C4277606
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	B:C1173940
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	B:C0079189
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	B:C0021760
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	B:C0041368
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	B:C0041368
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	B:C0012634
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	B:C0160390
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	B:C0030547
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	B:C0229671
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	B:C0031866
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	B:C1431711
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	O
tocopherol	I:C0969677
.	O

Liver	O
expression	O
of	O
canalicular	O
phospholipid	O
(	O
ABCB4	O
)	O
,	O
bile	O
acid	I:C0005390
(	O
ABCB11	O
)	O
,	O
and	O
sterol	O
(	O
ABCG5/	O
8	I:C0971221
)	O
transporters	O
,	O
their	O
upstream	O
regulators	I:C0033684
LXR	O
and	O
FXR	O
as	O
well	O
as	O
pro-inflammatory	O
cytokines	I:C0079189
interleukin	O
-	I:C0021760
6	I:C0021760
(	O
interleukin	O
-	I:C0021760
6	I:C0021760
)	O
and	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
(	O
tumor	O
necrosis	I:C0041368
factor	I:C0041368
)	O
were	O
investigated	O
among	O
patients	O
with	O
intestinal	O
failure	I:C0012634
[	O
age	O
median	O
3.8	O
(	O
IQR	O
1.2	O
to	O
11	O
)	O
]	O
in	O
relation	O
to	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
parenteral	O
nutrition	I:C0030547
,	O
serum	O
plant	O
sterols	I:C0031866
,	O
fibroblast	O
growth	I:C1431711
factor	I:C1431711
19	I:C1431711
,	O
and	O
α-	B:C0969677
tocopherol	I:C0969677
.	O

Patients	O
receiving	O
parenteral	B:C0030547
nutrition	I:C0030547
currently	O
(	O
n	O
=	O
18	O
)	O
showed	O
more	O
advanced	O
liver	O
injury	I:C0160390
than	O
patients	O
after	O
weaning	O
off	O
parenteral	O
nutrition	I:C0030547
(	O
n	O
=	O
30	O
)	O
.	O

Patients	O
receiving	O
parenteral	O
nutrition	I:C0030547
currently	O
(	O
n	O
=	O
18	O
)	O
showed	O
more	O
advanced	O
liver	B:C0160390
injury	I:C0160390
than	O
patients	O
after	O
weaning	O
off	O
parenteral	O
nutrition	I:C0030547
(	O
n	O
=	O
30	O
)	O
.	O

Patients	O
receiving	O
parenteral	O
nutrition	I:C0030547
currently	O
(	O
n	O
=	O
18	O
)	O
showed	O
more	O
advanced	O
liver	O
injury	I:C0160390
than	O
patients	O
after	O
weaning	B:C0043084
off	O
parenteral	O
nutrition	I:C0030547
(	O
n	O
=	O
30	O
)	O
.	O

Patients	O
receiving	O
parenteral	O
nutrition	I:C0030547
currently	O
(	O
n	O
=	O
18	O
)	O
showed	O
more	O
advanced	O
liver	O
injury	I:C0160390
than	O
patients	O
after	O
weaning	O
off	O
parenteral	B:C0030547
nutrition	I:C0030547
(	O
n	O
=	O
30	O
)	O
.	O

Histologic	O
portal	B:C2748698
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	O
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	O
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	O
and	O
liver	O
fibrosis	I:C0239946
.	O

Histologic	O
portal	O
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	B:C0030547
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	O
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	O
and	O
liver	O
fibrosis	I:C0239946
.	O

Histologic	O
portal	O
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	O
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	B:C0043084
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	O
and	O
liver	O
fibrosis	I:C0239946
.	O

Histologic	O
portal	O
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	O
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	O
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	B:C0242656
of	O
cholestasis	O
and	O
liver	O
fibrosis	I:C0239946
.	O

Histologic	O
portal	O
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	O
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	O
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	B:C0008370
and	O
liver	O
fibrosis	I:C0239946
.	O

Histologic	O
portal	O
inflammation	I:C2748698
strongly	O
segregated	O
parenteral	O
nutrition	I:C0030547
-	O
dependent	O
(	O
44	O
%	O
)	O
from	O
weaned	O
off	O
patients	O
(	O
3	O
%	O
,	O
P	O
=	O
0.001	O
)	O
and	O
coupled	O
with	O
progression	O
of	O
cholestasis	O
and	O
liver	B:C0239946
fibrosis	I:C0239946
.	O

Patients	O
with	O
portal	B:C2748698
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	B:C0023884
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	B:C0040649
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	B:C1334122
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	B:C0812246
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	B:C0920533
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	B:C1173940
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	B:C0005393
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	B:C0618375
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	B:C0017337
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	B:C0040649
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	B:C1412071
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	B:C1412070
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	B:C1171362
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	B:C1313221
and	O
ABCB4	O
.	O

Patients	O
with	O
portal	O
inflammation	I:C2748698
demonstrated	O
markedly	O
induced	O
liver	O
RNA	O
expression	I:C0040649
of	O
interleukin	O
-	I:C1334122
6	I:C1334122
and	O
tumor	O
necrosis	I:C0812246
factor	I:C0812246
,	O
repression	O
of	O
FXR	O
and	O
its	O
canalicular	O
bile	O
transporter	I:C0618375
target	O
gene	O
RNA	O
expression	I:C0040649
,	O
including	O
ABCB4	O
and	O
ABCB11	O
as	O
well	O
as	O
decreased	O
protein	O
expression	I:C1171362
of	O
ABCB11	O
and	O
ABCB4	B:C1260069
.	O

Furthermore	O
,	O
upregulation	B:C0041904
of	O
LXR	O
and	O
ABCG5/	O
8	I:C1422255
RNA	O
expression	I:C0040649
was	O
suppressed	O
in	O
patients	O
with	O
portal	O
inflammation	I:C2748698
.	O

Furthermore	O
,	O
upregulation	O
of	O
LXR	B:C4277606
and	O
ABCG5/	O
8	I:C1422255
RNA	O
expression	I:C0040649
was	O
suppressed	O
in	O
patients	O
with	O
portal	O
inflammation	I:C2748698
.	O

Furthermore	O
,	O
upregulation	O
of	O
LXR	O
and	O
ABCG5/	B:C1422255
8	I:C1422255
RNA	O
expression	I:C0040649
was	O
suppressed	O
in	O
patients	O
with	O
portal	O
inflammation	I:C2748698
.	O

Furthermore	O
,	O
upregulation	O
of	O
LXR	O
and	O
ABCG5/	O
8	I:C1422255
RNA	B:C0040649
expression	I:C0040649
was	O
suppressed	O
in	O
patients	O
with	O
portal	O
inflammation	I:C2748698
.	O

Furthermore	O
,	O
upregulation	O
of	O
LXR	O
and	O
ABCG5/	O
8	I:C1422255
RNA	O
expression	I:C0040649
was	O
suppressed	O
in	O
patients	O
with	O
portal	B:C2748698
inflammation	I:C2748698
.	O

Current	O
parenteral	B:C0030547
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	B:C0229671
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	B:C0031866
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	B:C0038329
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	B:C0031866
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	B:C0220914
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	B:C0229671
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	B:C0008864
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	B:C0005516
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	B:C0682610
mass	I:C0682610
,	O
predicted	O
portal	O
inflammation	I:C2748698
.	O

Current	O
parenteral	O
nutrition	I:C0030547
,	O
increased	O
serum	O
levels	O
of	O
plant	O
sterols	I:C0031866
stigmasterol	O
,	O
avenasterol	O
,	O
and	O
sitosterol	O
along	O
with	O
serum	O
citrulline	O
,	O
a	O
marker	O
of	O
enterocyte	O
mass	I:C0682610
,	O
predicted	O
portal	B:C2748698
inflammation	I:C2748698
.	O

In	O
pediatric	O
onset	O
intestinal	B:C0012634
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	B:C0030547
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	B:C0021853
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	B:C0019158
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	B:C0242656
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	B:C0160390
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	B:C1171362
of	O
canalicular	O
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	B:C0005393
bile	O
transporters	I:C0618375
.	O

In	O
pediatric	O
onset	O
intestinal	O
failure	I:C0012634
,	O
current	O
parenteral	O
nutrition	I:C0030547
delivery	O
synergistically	O
with	O
intestinal	O
compromise	O
promote	O
liver	O
inflammation	I:C0019158
,	O
which	O
associates	O
with	O
progression	O
of	O
biochemical	O
and	O
histologic	O
liver	O
injury	I:C0160390
,	O
while	O
reducing	O
expression	O
of	O
canalicular	O
bile	B:C0618375
transporters	I:C0618375
.	O

